Asset Management One’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,045
Closed -$1.24M 1042
2019
Q3
$1.24M Hold
1,045
0.01% 839
2019
Q2
$1.72M Buy
1,045
+201
+24% +$348K 0.01% 826
2019
Q1
$1.72M Hold
844
0.01% 817
2018
Q4
$1.06M Buy
844
+50
+6% +$76.7K ﹤0.01% 859
2018
Q3
$1.49M Buy
794
+240
+43% +$496K ﹤0.01% 844
2018
Q2
$1.11M Buy
554
+79
+17% +$180K ﹤0.01% 892
2018
Q1
$1.05M Buy
+475
New +$1.21M ﹤0.01% 880
2016
Q1
Sell
-1,932
Closed -$1.66M 1320
2015
Q4
$1.66M Buy
1,932
+48
+3% +$48K 0.02% 677
2015
Q3
$2.12M Sell
1,884
-276
-13% -$503K 0.03% 597
2015
Q2
$4.46M Buy
+2,160
New +$4.4M 0.06% 399

Other funds holding BLUE

Asset Management One's BLUE Position: Q4 2019 in Review

Asset Management One sold out of bluebird bio (BLUE) in Q4 2019, closing a stake of 1,045 shares — an estimated $1.24M sold.

Asset Management One first reported a position in BLUE in Q2 2015 and held it in 10 quarters. The position peaked at $4.46M in Q2 2015. 274 funds tracked by Wall St. Rank hold BLUE as of Q4 2019.

  • Asset Management One reported no remaining bluebird bio position as of Q4 2019 after selling out during the quarter.
  • Asset Management One sold 1,045 bluebird bio shares in Q4 2019, an estimated $1.24M.
  • Asset Management One first reported a position in bluebird bio in Q2 2015 and held it in 10 quarters.
  • Asset Management One's bluebird bio position peaked at $4.46M in Q2 2015.
  • 274 funds tracked by Wall St. Rank held bluebird bio as of Q4 2019.

Based on Asset Management One's 13F filing for Q4 2019, filed 14 Feb 2020.